Researchers at the Complutense University of Madrid (UCM) have identified changes in retinal layer thickness, inflammation or thinning in patients with mild Alzheimer’s disease, confirming that the retina is one of the most important biomarkers for early diagnosis of the disease.
For the first time, researchers have determined the shape and size of the areas that present significant thinning in each retinal layer, which tend to occur in the same locations.
They also observed that in some patients already diagnosed with Alzheimer’s disease, the retinal layers presented neurodegeneration,…